Physician profile
Nickeya Murphy
NPI 1639603608
$2,955.80
in general payments reported to CMS, 2019-2025
25 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,682 · 2022: $744 · 2023: $392 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $588.20 | 2021-2025 | Rybelsus, Ozempic |
| Abbvie INC. | $578.65 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $284.06 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $214.16 | 2021-2025 | Jardiance, Synjardy |
| Takeda Pharmaceuticals U.S.A., INC. | $189.67 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $175.30 | 2021-2023 | Farxiga |
| Lilly USA, LLC | $147.62 | 2021-2025 | Mounjaro, Emgality, Jardiance |
| Amarin Pharma, INC. | $145.94 | 2021 | |
| Pfizer INC. | $141.09 | 2021-2025 | |
| Amgen INC. | $88.27 | 2021-2025 | Repatha, Otezla |
| Glaxosmithkline, LLC. | $56.39 | 2021-2023 | Shingrix, Arexvy |
| Eisai INC. | $56.06 | 2021 | |
| Abbott Laboratories | $35.75 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $35.21 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $31.91 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $23.16 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $23.09 | 2022 | |
| Allergan, INC. | $21.24 | 2021 | |
| Shield Therapeutics INC | $19.72 | 2023 | Accrufer |
| Exact Sciences Corporation | $18.63 | 2025 | Cologuard Collection Kit |
| Medtronic, INC. | $18.33 | 2022 | |
| Almatica Pharma LLC | $17.84 | 2022 | |
| Pbg Puerto Rico LLC | $17.40 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.62 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nickeya Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.